Envestnet Asset Management Portfolio holdings
Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.
Top Buys
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$1.3B |
| 2 |
iShares Core High Dividend ETF
HDV
|
+$1.17B |
| 3 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$1.11B |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.11B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$898M |
Top Sells
Sector Composition
| 1 | Technology | 5.95% |
| 2 | Healthcare | 4.64% |
| 3 | Financials | 3.83% |
| 4 | Industrials | 2.7% |
| 5 | Consumer Discretionary | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Atara Biotherapeutics
ATRA
$85.5M
| $81K | ﹤0.01% |
418
-64
| -13% | -$12.4K |
|
|
EDAP
3777
EDAP TMS
EDAP
$94.2M
| $80K | ﹤0.01% |
+11,825
| New | +$80K |
|
3778
Acco Brands
ACCO
$364M
| $79K | ﹤0.01% |
12,165
-2,469
| -17% | -$16K |
|
3779
AvidXchange
AVDX
$2.06B
| $79K | ﹤0.01% |
12,918
-6,460
| -33% | -$39.5K |
|
3780
Liberty Latin America Class C
LILAK
$1.6B
| $79K | ﹤0.01% |
10,195
-548
| -5% | -$4.25K |
|
3781
Vuzix
VUZI
$179M
| $78K | ﹤0.01% |
11,023
-6,461
| -37% | -$45.7K |
|
|
GHG
3782
GreenTree Hospitality
GHG
$207M
| $77K | ﹤0.01% |
18,621
+2,726
| +17% | +$11.3K |
|
3783
Transocean
RIG
$2.98B
| $77K | ﹤0.01% |
23,031
-6,915
| -23% | -$23.1K |
|
3784
Under Armour Class C
UA
$2.11B
| $76K | ﹤0.01% |
10,025
-5,100
| -34% | -$38.7K |
|
|
CKPT
3785
DELISTED
Checkpoint Therapeutics
CKPT
| $73K | ﹤0.01% |
7,126
-654
| -8% | -$6.7K |
|
3786
Riskified
RSKD
$739M
| $73K | ﹤0.01% |
16,426
-1,660
| -9% | -$7.38K |
|
3787
Ardagh Metal Packaging
AMBP
$2.12B
| $72K | ﹤0.01% |
11,801
+266
| +2% | +$1.62K |
|
3788
Offerpad Solutions
OPAD
$130M
| $72K | ﹤0.01% |
+2,190
| New | +$72K |
|
3789
Oscar Health
OSCR
$5.24B
| $71K | ﹤0.01% |
16,610
+159
| +1% | +$680 |
|
|
JFIN
3790
Jiayin Group
JFIN
$592M
| $69K | ﹤0.01% |
30,635
+126
| +0.4% | +$284 |
|
3791
Apyx Medical
APYX
$77.9M
| $67K | ﹤0.01% |
11,443
-5,499
| -32% | -$32.2K |
|
|
BLRX
3792
BioLineRX
BLRX
$15.6M
| $66K | ﹤0.01% |
1,284
-445
| -26% | -$22.9K |
|
3793
Amneal Pharmaceuticals
AMRX
$3.02B
| $65K | ﹤0.01% |
20,295
-7,453
| -27% | -$23.9K |
|
|
IRS
3794
IRSA Inversiones y Representaciones
IRS
$960M
| $65K | ﹤0.01% |
17,297
-16,972
| -50% | -$63.8K |
|
3795
Kosmos Energy
KOS
$789M
| $65K | ﹤0.01% |
+10,579
| New | +$65K |
|
3796
SiriusPoint
SPNT
$2.21B
| $64K | ﹤0.01% |
11,839
-7,692
| -39% | -$41.6K |
|
|
NTCO
3797
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $64K | ﹤0.01% |
12,230
-1,207
| -9% | -$6.32K |
|
3798
FuelCell Energy
FCEL
$96.2M
| $62K | ﹤0.01% |
+548
| New | +$62K |
|
3799
Zymeworks
ZYME
$1.15B
| $62K | ﹤0.01% |
+11,614
| New | +$62K |
|
|
NTBL
3800
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $61K | ﹤0.01% |
1,088
+3
| +0.3% | +$168 |
|